William Muecke

CO-FOUNDING MANAGING MEMBER, ARTEMIS GROWTH PARTNERS LLC

Will Muecke is a co-founding managing member of Artemis Growth Partners, an ESG and impact-oriented private equity platform dedicated to investing 100% in the cannabis industry on a worldwide basis. Artemis Growth Partners oversees US $350+ million in mission-driven discretionary assets under management (AUM) invested in the global cannabis value chain, including branded products, distributors, value-added service providers, ancillary operators, and science-driven research and development platforms. Mr. Muecke co-founded Artemis Growth Partners in 2017 and since then has led investment origination, due diligence and execution staff management, deal processing, legal structuring, and exits. Mr. Muecke formerly was co-founder and managing partner of CoreCo Private Equity, a 2017 recipient of “Best for the World” impact investment funds as rated by B Analytics | GIIRS (Global Impact Investment Rating System), a sister company B Corporation and part of the B Labs family of impact rating services. Prior to co-founding CoreCo, Mr. Muecke was managing director and global co-head of the healthcare services sector in the healthcare investment banking group at Goldman, Sachs & Co. in New York City. Prior to his leadership role in the healthcare investment banking group, Mr. Muecke was global co-head of the mobile data sector in the communications, media, and entertainment group at Goldman, Sachs & Co. in San Francisco. Prior to his years at Goldman, Mr. Muecke was vice president and leveraged finance senior officer specializing in high yield debt, restructuring advisory, and leveraged buyouts at Donaldson, Lufkin & Jenrette in San Francisco. Over the duration of a 29-year career in global finance, Mr. Muecke developed expertise first as a banker in advisory, restructuring, and corporate finance, and then, later, as an investor in structuring, funding, and successfully exiting from private equity deals. Mr. Muecke’s technical skills in deal structuring, debt and equity funding, and merger negotiations across a wide variety of U.S. and international industries. Mr. Muecke maintains a world-class network of executive-level contacts at global corporations, institutional investors, large family offices, private investment firms, and commercial and investment banks. Mr. Muecke earned a Bachelor of Arts degree in English with a minor in Honors Chemistry from Cornell University and is a graduate of the FALCon Program in Japanese at Cornell’s Graduate School.

Attend Cannabis Europa London 2026

26–27 May 2026 · The Barbican, London · Europe's leading cannabis industry conference

General Release

£444
Price rises 1 May 2026
  • 2-Day Conference & Expo access
  • Full expo floor access
  • Digital networking app
  • All talks & presentations
  • Hot buffet lunch
  • Pre-bookable meeting rooms
  • Exclusive roundtables & insights
  • VIP Drinks, Barbican Conservatory
  • BoC Awards entry

BoC Awards

£50
Evening add-on · 26 May
  • Conference & Expo access
  • Daytime programme
  • Business of Cannabis Awards ceremony
  • Tuesday 26 May, 19:00–00:00
  • Rivington Street, London EC2A
  • Included free with VIP ticket
Working with Prohibition Partners for Cannabis Europa has been an absolute pleasure. Their dedication, exceptional professionalism, and collaborative spirit have made a meaningful difference, and we sincerely value their support.
Vladimir Kofcegarski, CEO, PHCANN
Vladimir Kofcegarski Chief Executive Officer, PHCANN
We were truly honoured to sponsor the VIP Lounge and be part of an event that continues to set the standard for meaningful dialogue and progress in the medical cannabis industry. We left feeling excited and optimistic about the future.
Adriano Fernandez
Adriano Fernandez Business Development Manager

Thank you for your interest!

Our team appreciates your engagement, and one of our managers will reach out to you shortly.